# MINOCIN® (minocycline) PDUFA date and FDA approval status

Canonical: https://sec-api.dev/pdufa/minocycline

> The FDA approved MINOCIN® (minocycline), sponsored by Journey Medical Corp (DERM), on November 1, 2024.

Data as of November 16, 2026 (snapshot 20261116T222116Z). Every date quotes the SEC filing or FDA page it came from. Date precision: exact day.

**Free:** every drug page and the next 30 days of the FDA calendar, no account. Calendar API, alerts when a date moves, and full history: https://sec-api.dev/pricing . Free API key: https://sec-api.dev/sign-up?ref=ai-claudebot

## Key facts

| Field | Value |
| --- | --- |
| Drug | MINOCIN® (minocycline) |
| Codes |  |
| Sponsor | Journey Medical Corp (DERM) https://sec-api.dev/companies/derm/catalysts |
| Indications |  |
| Modality |  |
| FDA designations | none disclosed |

## Timeline

### October 18, 2019: FDA approval

- Status: completed, approved. Date confidence: exact.
- First seen 2026-11-12T03:44:55.771Z, last confirmed 2026-11-16T22:20:01.192Z.
- openFDA Drugs@FDA: "NDA212379 ORIG-1 (Type 3 - New Dosage Form): submission_status AP, submission_status_date 20191018, review_priority STANDARD; sponsor_name JOURNEY; product AMZEEQ (MINOCYCLINE HYDROCHLORIDE)." https://api.fda.gov/drug/drugsfda.json?search=application_number:%22NDA212379%22

### May 28, 2020: FDA approval

- Status: completed, approved. Date confidence: exact.
- First seen 2026-11-12T03:44:55.771Z, last confirmed 2026-11-16T22:20:01.192Z.
- openFDA Drugs@FDA: "NDA213690 ORIG-1 (Type 5 - New Formulation or New Manufacturer): submission_status AP, submission_status_date 20200528, review_priority STANDARD; sponsor_name JOURNEY; product ZILXI (MINOCYCLINE HYDROCHLORIDE)." https://api.fda.gov/drug/drugsfda.json?search=application_number:%22NDA213690%22

### November 1, 2024: FDA approval

- Status: completed, approved. Date confidence: exact.
- First seen 2025-03-31, last confirmed 2026-11-16T22:20:01.192Z.
- openFDA Drugs@FDA: "NDA219015 ORIG-1 (Type 5 - New Formulation or New Manufacturer): submission_status AP, submission_status_date 20241101, review_priority STANDARD; sponsor_name JOURNEY; product EMROSI (MINOCYCLINE HYDROCHLORIDE)." https://api.fda.gov/drug/drugsfda.json?search=application_number:%22NDA219015%22
- Press release filed with the SEC (EX-99) (accession 0001558370-25-007878): "In November 2024, the FDA approved Emrosi (Minocycline Hydrochloride Extended-Release Capsules, 40mg), also known as DFD-29." https://www.sec.gov/Archives/edgar/data/1429260/000155837025007878/fbio-20250515xex99.htm
- Press release filed with the SEC (EX-99) (accession 0001558370-25-004154): "In November 2024, the U.S. Food and Drug Administration ("FDA") approved Emrosi (Minocycline Hydrochloride Extended-Release Capsules, 40mg), also known as DFD-29." https://www.sec.gov/Archives/edgar/data/1429260/000155837025004154/fbio-20250331xex99d1.htm

## Feeds and downloads

- Subscribe (iCal): https://sec-api.dev/pdufa/minocycline.ics
- Next 30 days as CSV: https://sec-api.dev/fda-calendar.csv . JSON: https://sec-api.dev/fda-calendar.json . All events (iCal): https://sec-api.dev/fda-calendar.ics
- New or moved PDUFA dates: https://sec-api.dev/pdufa-dates/feed.xml (RSS), https://sec-api.dev/pdufa-dates/feed.json (JSON Feed)
- FDA approvals: https://sec-api.dev/fda-approvals-today/feed.xml (RSS), https://sec-api.dev/fda-approvals-today/feed.json (JSON Feed)
- License: CC BY 4.0 for the public 30-day window (https://sec-api.dev/biotech/license.txt). Full history: https://sec-api.dev/pricing

## Cite this page

sec-api.dev. "MINOCIN® (minocycline) PDUFA date and FDA approval status." Biotech catalyst calendar, data as of November 16, 2026 (snapshot 20261116T222116Z). https://sec-api.dev/pdufa/minocycline

```bibtex
@misc{secapidev_pdufa_minocycline_20261116,
  title        = {MINOCIN® (minocycline) PDUFA date and FDA approval status},
  author       = {{sec-api.dev}},
  year         = {2026},
  month        = {nov},
  howpublished = {\url{https://sec-api.dev/pdufa/minocycline}},
  note         = {Biotech catalyst calendar, data as of 2026-11-16, snapshot 20261116T222116Z. Compiled from SEC EDGAR filings, FDA and ClinicalTrials.gov; each date quotes its source.}
}
```

```json
{"type":"dataset","id":"secapidev_pdufa_minocycline_20261116","title":"MINOCIN® (minocycline) PDUFA date and FDA approval status","publisher":"sec-api.dev","URL":"https://sec-api.dev/pdufa/minocycline","issued":{"date-parts":[[2026,11,16]]},"version":"20261116T222116Z","license":"https://creativecommons.org/licenses/by/4.0/","note":"Compiled from SEC EDGAR filings, FDA and ClinicalTrials.gov; each date quotes its source."}
```

---
Independent. Not affiliated with, endorsed by, or sponsored by the U.S. Food and Drug Administration or the U.S. Securities and Exchange Commission. Dates are as stated by sponsors and FDA; the FDA can act before or after a target date. Not investment advice.
